Pharmafile Logo
Pharmafocus logo
Advanced Search

J&J

Showing 15 posts of 227 posts found.

J&J image

J&J seeks end to Doxil shortage as Ben Venue signs consent decree

January 28, 2013
Manufacturing and Production Ben Venue, Boehringer, Caelyx, Doxil, J&J, JJ, Janssen

Johnson & Johnson says it has taken steps to establish new supplies of its cancer drug Doxil/Caelyx, which remains in …

News
Zytiga image

Zytiga extended in EU

January 15, 2013
Sales and Marketing EU, J&J, JJ, Janssen, Zytiga

Janssen is celebrating the European Commission’s decision to extend the licence for its prostate cancer treatment Zytiga. The once-daily pill …

News
FDA image

FDA vote on J&J diabetes drug

January 10, 2013
Sales and Marketing EU, FDA, J&J, JJ, Janssen, canagliflozin

Key advisers to the FDA are meeting today to decide whether Janssen Pharmaceuticals’ type II diabetes drug canagliflozin is safe …

News
eugene_washington-iha-005108

Eugene Washington appointed to J&J Board of directors

November 13, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eugene Washington, J&J, JJ

Dr Eugene Washington has been appointed to the Board of directors at Johnson & Johnson. Washington serves as vice chancellor …

Appointment
J&J image

J&J profits down in Q3

October 17, 2012
Sales and Marketing J&J, JJ, Johnson & Johnson, Q3, Risperdal

Johnson & Johnson has reported a 6.5% year-on-year sales increase to $17.1 billion in the third quarter of 2012, a …

News
J&J image

Johnson & Johnson revamps manufacturing once again

October 15, 2012
Manufacturing and Production Gurabo, J&J, JJ, Puerto Rico

Johnson & Johnson continues to restructure its manufacturing network, expanding production at plants in Puerto Rico whilst setting up a …

News

J&J cancer drugs get EU approval

October 2, 2012
Sales and Marketing Cancer, Dacogen, EU, J&J, JJ, Velcade

Two of Johnson & Johnson’s key cancer drugs have been shown the green light from the European Commission. Janssen-Cilag International’s …

News
27

Amgen names Ray Jordan senior VP Corporate Affairs

September 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, J&J, JJ, Ray Jordan

Amgen has announced the appointment of ex-J&J comms leader Ray Jordan to the new position of senior vice president, Corporate …

Appointment
peterson_600

Sandra Peterson joins J&J’s executive committee

September 20, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing J&J, JJ, Sandra Peterson

Sandra Peterson will join Johnson & Johnson on 1 December as Group Worldwide chairman and member of the company’s executive …

Appointment
johnson and johnson image

J&J sets up life science centres

September 19, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, R&D, innovation

Johnson & Johnson is to set up what it calls regional innovation centres in a bid to speed up the …

News

Smoke and fire in J&J Code breach

August 15, 2012
Sales and Marketing Champix, J&J, JJ, Johnson and Johnson, PMCPA, Pfizer

Johnson & Johnson has been censured for breaking the ABPI Code of Practice in printed information about its smoking cessation …

News
J&J image

J&J expects consent decree to extend through ‘most of 2013’

July 30, 2012
Manufacturing and Production FDA, J&J, JJ, McNeil, OTC, recall

Johnson & Johnson has said it expects the production capacity issues affecting two plants covered by a consent decree with …

News

New J&J chief still struggling with scandals

July 18, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Gorsky, J&J, JJ, Risperdal, Weldon, Xarelto, Zytiga

Johnson & Johnson has just released its Q2 figures showing sales fell back in the second quarter, a 3.5% growth …

Feature
FDA image

Janssen submits tuberculosis pill to FDA

July 4, 2012
Research and Development, Sales and Marketing Bedaquiline, FDA, J&J, JJ, Janssen, tuberculosis

Janssen has submitted its investigational tuberculosis pill bedaquiline for review by the FDA. The firm is seeking a licence for …

News
Xarelto image

FDA rejects licence extension for Xarelto

June 26, 2012
Sales and Marketing ACS, Bayer, FDA, J&J, JJ, Pradaxa, Xarelto

The FDA has set a Complete Response Letter to Bayer and J&J over its blood thinner Xarelto. The firms, which …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026